サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1374628

世界の薬物リハビリテーション市場：考察と予測 (2029年まで)

Global Drug Rehabilitation Drugs Market Insights, Forecast to 2029
出版日: | 発行: QYResearch | ページ情報: 英文 105 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
世界の薬物リハビリテーション市場：考察と予測 (2029年まで)
出版日: 2023年11月07日
発行: QYResearch
ページ情報: 英文 105 Pages
納期: 2～3営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートは、薬物リハビリテーション (Drug Rehabilitation Drugs) 市場について調査しており、市場規模や動向・需要の予測、成長要因および課題の分析、タイプ・用途・企業・地域別の内訳、競合情勢、主要企業のプロファイルなどの情報を提供しています。

目次

第1章 調査対象

  • 薬物リハビリテーションの製品概要
  • 市場：タイプ別
    • 世界の薬物リハビリテーションの市場規模成長率：タイプ別, 2018 VS 2022 VS 2029
    • Opioids
    • Non-opioid Drugs
  • 市場：用途別
    • 世界の薬物リハビリテーションの市場規模成長率：用途別, 2018 VS 2022 VS 2029
    • Hospital
    • Clinic
  • 前提条件と制限
  • 調査目的
  • 対象期間

第2章 レポート概要

  • 世界の薬物リハビリテーション売上予測・予想 2018-2029
  • 世界の薬物リハビリテーションの収益：地域別
    • 世界の薬物リハビリテーションの収益：地域別: 2018 VS 2022 VS 2029
    • 世界の薬物リハビリテーションの収益：地域別 (2018-2023)
    • 世界の薬物リハビリテーションの収益：地域別 (2024-2029)
    • 世界の薬物リハビリテーションの収益市場シェア 地域別 (2018-2029)
  • 世界の薬物リハビリテーション売上予測・予想 2018-2029
  • 世界の薬物リハビリテーションの販売：地域別
    • 世界の薬物リハビリテーションの販売：地域別: 2018 VS 2022 VS 2029
    • 世界の薬物リハビリテーションの販売：地域別 (2018-2023)
    • 世界の薬物リハビリテーションの販売：地域別 (2024-2029)
    • 世界の薬物リハビリテーションの販売市場シェア 地域別 (2018-2029)
  • 米国・カナダ
  • 欧州
  • 中国
  • アジア（中国を除く）
  • 中東, アフリカ ・ラテンアメリカ

第3章 競合：企業別

  • 世界の薬物リハビリテーションの販売：企業別
    • 世界の薬物リハビリテーションの販売：企業別 (2018-2023)
    • 世界の薬物リハビリテーションの販売市場シェア：企業別 (2018-2023)
    • 世界の上位10・上位5企業： 薬物リハビリテーション in 2022
  • 世界の薬物リハビリテーションの収益：企業別
    • 世界の薬物リハビリテーションの収益：企業別 (2018-2023)
    • 世界の薬物リハビリテーションの収益市場シェア：企業別 (2018-2023)
    • 世界の上位10・上位5企業： 薬物リハビリテーションの収益 2022
  • 世界の主要企業 薬物リハビリテーション, 業界ランキング, 2021 VS 2022 VS 2023
  • 世界の薬物リハビリテーションの販売価格：企業別
  • 競合情勢の分析
    • 企業の市場集中度 (CR5 and HHI)
    • 世界の薬物リハビリテーションの市場シェア：企業タイプ別 (Tier 1, Tier 2, and Tier 3)
  • 世界の主要メーカー 薬物リハビリテーション, 製造拠点分布と本社
  • 世界の主要メーカー 薬物リハビリテーション, 提供製品と用途
  • 世界の主要メーカー 薬物リハビリテーション, 業界参入時期
  • M&A, 拡張計画

第4章 市場規模：タイプ別

  • 世界の薬物リハビリテーションの販売：タイプ別
    • 世界の薬物リハビリテーションの販売実績：タイプ別 (2018-2023)
    • 世界の薬物リハビリテーションの販売予測：タイプ別 (2024-2029)
    • 世界の薬物リハビリテーションの販売市場シェア：タイプ別 (2018-2029)
  • 世界の薬物リハビリテーション 収益：タイプ別
    • 世界の薬物リハビリテーションの収益実績：タイプ別 (2018-2023)
    • 世界の薬物リハビリテーションの収益予測：タイプ別 (2024-2029)
    • 世界の薬物リハビリテーションの収益市場シェア：タイプ別 (2018-2029)
  • 世界の薬物リハビリテーションの価格：タイプ別
    • 世界の薬物リハビリテーションの価格：タイプ別 (2018-2023)
    • 世界の薬物リハビリテーションの価格予測：タイプ別 (2024-2029)

第5章 市場規模：用途別

  • 世界の薬物リハビリテーションの販売：用途別
    • 世界の薬物リハビリテーションの販売実績：用途別 (2018-2023)
    • 世界の薬物リハビリテーションの販売予測：用途別 (2024-2029)
    • 世界の薬物リハビリテーションの販売市場シェア：用途別 (2018-2029)
  • 世界の薬物リハビリテーションの収益：用途別
    • 世界の薬物リハビリテーションの収益実績：用途別 (2018-2023)
    • 世界の薬物リハビリテーションの収益予測：用途別 (2024-2029)
    • 世界の薬物リハビリテーションの収益市場シェア：用途別 (2018-2029)
  • 世界の薬物リハビリテーションの価格：用途別
    • 世界の薬物リハビリテーションの価格：用途別 (2018-2023)
    • 世界の薬物リハビリテーションの価格予測：用途別 (2024-2029)

第6章 米国・カナダ

  • 米国・カナダ 薬物リハビリテーション 市場規模：タイプ別
    • 米国・カナダ 薬物リハビリテーションの販売：タイプ別 (2018-2029)
    • 米国・カナダ 薬物リハビリテーション 収益：タイプ別 (2018-2029)
  • 米国・カナダ 薬物リハビリテーション 市場規模：用途別
    • 米国・カナダ 薬物リハビリテーションの販売：用途別 (2018-2029)
    • 米国・カナダ 薬物リハビリテーションの収益：用途別 (2018-2029)
  • 米国・カナダ 薬物リハビリテーション 市場規模：国別
    • 米国・カナダ 薬物リハビリテーションの収益：国別: 2018 VS 2022 VS 2029
    • 米国・カナダ 薬物リハビリテーションの販売：国別 (2018-2029)
    • 米国・カナダ 薬物リハビリテーションの収益：国別 (2018-2029)
    • US
    • カナダ

第7章 欧州

  • 欧州の薬物リハビリテーション 市場規模：タイプ別
    • 欧州の薬物リハビリテーションの販売：タイプ別 (2018-2029)
    • 欧州の薬物リハビリテーション 収益：タイプ別 (2018-2029)
  • 欧州の薬物リハビリテーション 市場規模：用途別
    • 欧州の薬物リハビリテーションの販売：用途別 (2018-2029)
    • 欧州の薬物リハビリテーションの収益：用途別 (2018-2029)
  • 欧州の薬物リハビリテーション 市場規模：国別
    • 欧州の薬物リハビリテーションの収益：国別: 2018 VS 2022 VS 2029
    • 欧州の薬物リハビリテーションの販売：国別 (2018-2029)
    • 欧州の薬物リハビリテーションの収益：国別 (2018-2029)
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • ロシア

第8章 中国

  • 中国の薬物リハビリテーション 市場規模
    • 中国の薬物リハビリテーション 売上 (2018-2029)
    • 中国の薬物リハビリテーション 収益 (2018-2029)
  • 中国の薬物リハビリテーション 市場規模：用途別
    • 中国の薬物リハビリテーションの販売：用途別 (2018-2029)
    • 中国の薬物リハビリテーションの収益：用途別 (2018-2029)

第9章 アジア（中国を除く）

  • アジア地域 薬物リハビリテーション 市場規模：タイプ別
    • アジア地域 薬物リハビリテーションの販売：タイプ別 (2018-2029)
    • アジア地域 薬物リハビリテーション 収益：タイプ別 (2018-2029)
  • アジア地域 薬物リハビリテーション 市場規模：用途別
    • アジア地域 薬物リハビリテーションの販売：用途別 (2018-2029)
    • アジア地域 薬物リハビリテーションの収益：用途別 (2018-2029)
  • アジア地域 薬物リハビリテーションの販売：地域別
    • アジア地域 薬物リハビリテーションの収益：地域別: 2018 VS 2022 VS 2029
    • アジア地域 薬物リハビリテーションの収益：地域別 (2018-2029)
    • アジア地域 薬物リハビリテーションの販売：地域別 (2018-2029)
    • 日本
    • 韓国
    • 台湾
    • 東南アジア
    • インド

第10章 中東, アフリカ ・ラテンアメリカ

  • 中東, アフリカ ・ラテンアメリカの薬物リハビリテーション 市場規模：タイプ別
    • 中東, アフリカ ・ラテンアメリカの薬物リハビリテーションの販売：タイプ別 (2018-2029)
    • 中東, アフリカ ・ラテンアメリカの薬物リハビリテーション 収益：タイプ別 (2018-2029)
  • 中東, アフリカ ・ラテンアメリカの薬物リハビリテーション 市場規模：用途別
    • 中東, アフリカ ・ラテンアメリカの薬物リハビリテーションの販売：用途別 (2018-2029)
    • 中東, アフリカ ・ラテンアメリカの薬物リハビリテーションの収益：用途別 (2018-2029)
  • 中東, アフリカ ・ラテンアメリカの薬物リハビリテーションの販売：国別
    • 中東, アフリカ ・ラテンアメリカの薬物リハビリテーションの収益：国別: 2018 VS 2022 VS 2029
    • 中東, アフリカ ・ラテンアメリカの薬物リハビリテーションの収益：国別 (2018-2029)
    • 中東, アフリカ ・ラテンアメリカの薬物リハビリテーションの販売：国別 (2018-2029)
    • ブラジル
    • メキシコ
    • トルコ
    • イスラエル
    • 湾岸協力理事会諸国

第11章 企業プロファイル

  • Teva
  • Purdue Pharma
  • Mallinckrodt
  • Amneal Pharma
  • Collegium
  • J&J
  • Endo
  • Pfizer
  • INSYS
  • Mylan
  • Hikma
  • Egalet

第12章 業界チェーンと販売チャネルの分析

  • 薬物リハビリテーション 業界チェーン分析
  • 薬物リハビリテーション 主要原材料
    • 主要原材料
    • 原材料の主要サプライヤー
  • 薬物リハビリテーション 生産形態とプロセス
  • 薬物リハビリテーション 販売およびマーケティング
    • 薬物リハビリテーション 販売チャネルs
    • 薬物リハビリテーション 卸業者
  • 薬物リハビリテーション 顧客

第13章 市場動向

  • 薬物リハビリテーション 業界動向
  • 薬物リハビリテーション 市場の促進要因
  • 薬物リハビリテーション 市場の課題
  • 薬物リハビリテーション 市場の抑制要因

第14章 主な調査結果 世界の薬物リハビリテーションの主な市場調査結果

第15章 付録

図表

List of Tables

  • Table 1. Global Drug Rehabilitation Drugs Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
  • Table 2. Major Manufacturers of Opioids
  • Table 3. Major Manufacturers of Non-opioid Drugs
  • Table 4. Global Drug Rehabilitation Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
  • Table 5. Global Drug Rehabilitation Drugs Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
  • Table 6. Global Drug Rehabilitation Drugs Revenue by Region (2018-2023) & (US$ Million)
  • Table 7. Global Drug Rehabilitation Drugs Revenue by Region (2024-2029) & (US$ Million)
  • Table 8. Global Drug Rehabilitation Drugs Revenue Market Share by Region (2018-2023)
  • Table 9. Global Drug Rehabilitation Drugs Revenue Market Share by Region (2024-2029)
  • Table 10. Global Drug Rehabilitation Drugs Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
  • Table 11. Global Drug Rehabilitation Drugs Sales by Region (2018-2023) & (K Units)
  • Table 12. Global Drug Rehabilitation Drugs Sales by Region (2024-2029) & (K Units)
  • Table 13. Global Drug Rehabilitation Drugs Sales Market Share by Region (2018-2023)
  • Table 14. Global Drug Rehabilitation Drugs Sales Market Share by Region (2024-2029)
  • Table 15. Global Drug Rehabilitation Drugs Sales by Manufacturers (2018-2023) & (K Units)
  • Table 16. Global Drug Rehabilitation Drugs Sales Share by Manufacturers (2018-2023)
  • Table 17. Global Drug Rehabilitation Drugs Revenue by Manufacturers (2018-2023) & (US$ Million)
  • Table 18. Global Drug Rehabilitation Drugs Revenue Share by Manufacturers (2018-2023)
  • Table 19. Global Key Players of Drug Rehabilitation Drugs, Industry Ranking, 2021 VS 2022 VS 2023
  • Table 20. Drug Rehabilitation Drugs Price by Manufacturers 2018-2023 (US$/Unit)
  • Table 21. Global Drug Rehabilitation Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
  • Table 22. Global Drug Rehabilitation Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Rehabilitation Drugs as of 2022)
  • Table 23. Global Key Manufacturers of Drug Rehabilitation Drugs, Manufacturing Base Distribution and Headquarters
  • Table 24. Global Key Manufacturers of Drug Rehabilitation Drugs, Product Offered and Application
  • Table 25. Global Key Manufacturers of Drug Rehabilitation Drugs, Date of Enter into This Industry
  • Table 26. Mergers & Acquisitions, Expansion Plans
  • Table 27. Global Drug Rehabilitation Drugs Sales by Type (2018-2023) & (K Units)
  • Table 28. Global Drug Rehabilitation Drugs Sales by Type (2024-2029) & (K Units)
  • Table 29. Global Drug Rehabilitation Drugs Sales Share by Type (2018-2023)
  • Table 30. Global Drug Rehabilitation Drugs Sales Share by Type (2024-2029)
  • Table 31. Global Drug Rehabilitation Drugs Revenue by Type (2018-2023) & (US$ Million)
  • Table 32. Global Drug Rehabilitation Drugs Revenue by Type (2024-2029) & (US$ Million)
  • Table 33. Global Drug Rehabilitation Drugs Revenue Share by Type (2018-2023)
  • Table 34. Global Drug Rehabilitation Drugs Revenue Share by Type (2024-2029)
  • Table 35. Drug Rehabilitation Drugs Price by Type (2018-2023) & (US$/Unit)
  • Table 36. Global Drug Rehabilitation Drugs Price Forecast by Type (2024-2029) & (US$/Unit)
  • Table 37. Global Drug Rehabilitation Drugs Sales by Application (2018-2023) & (K Units)
  • Table 38. Global Drug Rehabilitation Drugs Sales by Application (2024-2029) & (K Units)
  • Table 39. Global Drug Rehabilitation Drugs Sales Share by Application (2018-2023)
  • Table 40. Global Drug Rehabilitation Drugs Sales Share by Application (2024-2029)
  • Table 41. Global Drug Rehabilitation Drugs Revenue by Application (2018-2023) & (US$ Million)
  • Table 42. Global Drug Rehabilitation Drugs Revenue by Application (2024-2029) & (US$ Million)
  • Table 43. Global Drug Rehabilitation Drugs Revenue Share by Application (2018-2023)
  • Table 44. Global Drug Rehabilitation Drugs Revenue Share by Application (2024-2029)
  • Table 45. Drug Rehabilitation Drugs Price by Application (2018-2023) & (US$/Unit)
  • Table 46. Global Drug Rehabilitation Drugs Price Forecast by Application (2024-2029) & (US$/Unit)
  • Table 47. US & Canada Drug Rehabilitation Drugs Sales by Type (2018-2023) & (K Units)
  • Table 48. US & Canada Drug Rehabilitation Drugs Sales by Type (2024-2029) & (K Units)
  • Table 49. US & Canada Drug Rehabilitation Drugs Revenue by Type (2018-2023) & (US$ Million)
  • Table 50. US & Canada Drug Rehabilitation Drugs Revenue by Type (2024-2029) & (US$ Million)
  • Table 51. US & Canada Drug Rehabilitation Drugs Sales by Application (2018-2023) & (K Units)
  • Table 52. US & Canada Drug Rehabilitation Drugs Sales by Application (2024-2029) & (K Units)
  • Table 53. US & Canada Drug Rehabilitation Drugs Revenue by Application (2018-2023) & (US$ Million)
  • Table 54. US & Canada Drug Rehabilitation Drugs Revenue by Application (2024-2029) & (US$ Million)
  • Table 55. US & Canada Drug Rehabilitation Drugs Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
  • Table 56. US & Canada Drug Rehabilitation Drugs Revenue by Country (2018-2023) & (US$ Million)
  • Table 57. US & Canada Drug Rehabilitation Drugs Revenue by Country (2024-2029) & (US$ Million)
  • Table 58. US & Canada Drug Rehabilitation Drugs Sales by Country (2018-2023) & (K Units)
  • Table 59. US & Canada Drug Rehabilitation Drugs Sales by Country (2024-2029) & (K Units)
  • Table 60. Europe Drug Rehabilitation Drugs Sales by Type (2018-2023) & (K Units)
  • Table 61. Europe Drug Rehabilitation Drugs Sales by Type (2024-2029) & (K Units)
  • Table 62. Europe Drug Rehabilitation Drugs Revenue by Type (2018-2023) & (US$ Million)
  • Table 63. Europe Drug Rehabilitation Drugs Revenue by Type (2024-2029) & (US$ Million)
  • Table 64. Europe Drug Rehabilitation Drugs Sales by Application (2018-2023) & (K Units)
  • Table 65. Europe Drug Rehabilitation Drugs Sales by Application (2024-2029) & (K Units)
  • Table 66. Europe Drug Rehabilitation Drugs Revenue by Application (2018-2023) & (US$ Million)
  • Table 67. Europe Drug Rehabilitation Drugs Revenue by Application (2024-2029) & (US$ Million)
  • Table 68. Europe Drug Rehabilitation Drugs Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
  • Table 69. Europe Drug Rehabilitation Drugs Revenue by Country (2018-2023) & (US$ Million)
  • Table 70. Europe Drug Rehabilitation Drugs Revenue by Country (2024-2029) & (US$ Million)
  • Table 71. Europe Drug Rehabilitation Drugs Sales by Country (2018-2023) & (K Units)
  • Table 72. Europe Drug Rehabilitation Drugs Sales by Country (2024-2029) & (K Units)
  • Table 73. China Drug Rehabilitation Drugs Sales by Type (2018-2023) & (K Units)
  • Table 74. China Drug Rehabilitation Drugs Sales by Type (2024-2029) & (K Units)
  • Table 75. China Drug Rehabilitation Drugs Revenue by Type (2018-2023) & (US$ Million)
  • Table 76. China Drug Rehabilitation Drugs Revenue by Type (2024-2029) & (US$ Million)
  • Table 77. China Drug Rehabilitation Drugs Sales by Application (2018-2023) & (K Units)
  • Table 78. China Drug Rehabilitation Drugs Sales by Application (2024-2029) & (K Units)
  • Table 79. China Drug Rehabilitation Drugs Revenue by Application (2018-2023) & (US$ Million)
  • Table 80. China Drug Rehabilitation Drugs Revenue by Application (2024-2029) & (US$ Million)
  • Table 81. Asia Drug Rehabilitation Drugs Sales by Type (2018-2023) & (K Units)
  • Table 82. Asia Drug Rehabilitation Drugs Sales by Type (2024-2029) & (K Units)
  • Table 83. Asia Drug Rehabilitation Drugs Revenue by Type (2018-2023) & (US$ Million)
  • Table 84. Asia Drug Rehabilitation Drugs Revenue by Type (2024-2029) & (US$ Million)
  • Table 85. Asia Drug Rehabilitation Drugs Sales by Application (2018-2023) & (K Units)
  • Table 86. Asia Drug Rehabilitation Drugs Sales by Application (2024-2029) & (K Units)
  • Table 87. Asia Drug Rehabilitation Drugs Revenue by Application (2018-2023) & (US$ Million)
  • Table 88. Asia Drug Rehabilitation Drugs Revenue by Application (2024-2029) & (US$ Million)
  • Table 89. Asia Drug Rehabilitation Drugs Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
  • Table 90. Asia Drug Rehabilitation Drugs Revenue by Region (2018-2023) & (US$ Million)
  • Table 91. Asia Drug Rehabilitation Drugs Revenue by Region (2024-2029) & (US$ Million)
  • Table 92. Asia Drug Rehabilitation Drugs Sales by Region (2018-2023) & (K Units)
  • Table 93. Asia Drug Rehabilitation Drugs Sales by Region (2024-2029) & (K Units)
  • Table 94. Middle East, Africa and Latin America Drug Rehabilitation Drugs Sales by Type (2018-2023) & (K Units)
  • Table 95. Middle East, Africa and Latin America Drug Rehabilitation Drugs Sales by Type (2024-2029) & (K Units)
  • Table 96. Middle East, Africa and Latin America Drug Rehabilitation Drugs Revenue by Type (2018-2023) & (US$ Million)
  • Table 97. Middle East, Africa and Latin America Drug Rehabilitation Drugs Revenue by Type (2024-2029) & (US$ Million)
  • Table 98. Middle East, Africa and Latin America Drug Rehabilitation Drugs Sales by Application (2018-2023) & (K Units)
  • Table 99. Middle East, Africa and Latin America Drug Rehabilitation Drugs Sales by Application (2024-2029) & (K Units)
  • Table 100. Middle East, Africa and Latin America Drug Rehabilitation Drugs Revenue by Application (2018-2023) & (US$ Million)
  • Table 101. Middle East, Africa and Latin America Drug Rehabilitation Drugs Revenue by Application (2024-2029) & (US$ Million)
  • Table 102. Middle East, Africa and Latin America Drug Rehabilitation Drugs Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
  • Table 103. Middle East, Africa and Latin America Drug Rehabilitation Drugs Revenue by Country (2018-2023) & (US$ Million)
  • Table 104. Middle East, Africa and Latin America Drug Rehabilitation Drugs Revenue by Country (2024-2029) & (US$ Million)
  • Table 105. Middle East, Africa and Latin America Drug Rehabilitation Drugs Sales by Country (2018-2023) & (K Units)
  • Table 106. Middle East, Africa and Latin America Drug Rehabilitation Drugs Sales by Country (2024-2029) & (K Units)
  • Table 107. Teva Company Information
  • Table 108. Teva Description and Major Businesses
  • Table 109. Teva Drug Rehabilitation Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
  • Table 110. Teva Drug Rehabilitation Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 111. Teva Recent Developments
  • Table 112. Purdue Pharma Company Information
  • Table 113. Purdue Pharma Description and Major Businesses
  • Table 114. Purdue Pharma Drug Rehabilitation Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
  • Table 115. Purdue Pharma Drug Rehabilitation Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 116. Purdue Pharma Recent Developments
  • Table 117. Mallinckrodt Company Information
  • Table 118. Mallinckrodt Description and Major Businesses
  • Table 119. Mallinckrodt Drug Rehabilitation Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
  • Table 120. Mallinckrodt Drug Rehabilitation Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 121. Mallinckrodt Recent Developments
  • Table 122. Amneal Pharma Company Information
  • Table 123. Amneal Pharma Description and Major Businesses
  • Table 124. Amneal Pharma Drug Rehabilitation Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
  • Table 125. Amneal Pharma Drug Rehabilitation Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 126. Amneal Pharma Recent Developments
  • Table 127. Collegium Company Information
  • Table 128. Collegium Description and Major Businesses
  • Table 129. Collegium Drug Rehabilitation Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
  • Table 130. Collegium Drug Rehabilitation Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 131. Collegium Recent Developments
  • Table 132. J&J Company Information
  • Table 133. J&J Description and Major Businesses
  • Table 134. J&J Drug Rehabilitation Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
  • Table 135. J&J Drug Rehabilitation Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 136. J&J Recent Developments
  • Table 137. Endo Company Information
  • Table 138. Endo Description and Major Businesses
  • Table 139. Endo Drug Rehabilitation Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
  • Table 140. Endo Drug Rehabilitation Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 141. Endo Recent Developments
  • Table 142. Pfizer Company Information
  • Table 143. Pfizer Description and Major Businesses
  • Table 144. Pfizer Drug Rehabilitation Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
  • Table 145. Pfizer Drug Rehabilitation Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 146. Pfizer Recent Developments
  • Table 147. INSYS Company Information
  • Table 148. INSYS Description and Major Businesses
  • Table 149. INSYS Drug Rehabilitation Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
  • Table 150. INSYS Drug Rehabilitation Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 151. INSYS Recent Developments
  • Table 152. Mylan Company Information
  • Table 153. Mylan Description and Major Businesses
  • Table 154. Mylan Drug Rehabilitation Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
  • Table 155. Mylan Drug Rehabilitation Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 156. Mylan Recent Developments
  • Table 157. Hikma Company Information
  • Table 158. Hikma Description and Major Businesses
  • Table 159. Hikma Drug Rehabilitation Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
  • Table 160. Hikma Drug Rehabilitation Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 161. Hikma Recent Developments
  • Table 162. Egalet Company Information
  • Table 163. Egalet Description and Major Businesses
  • Table 164. Egalet Drug Rehabilitation Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
  • Table 165. Egalet Drug Rehabilitation Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 166. Egalet Recent Developments
  • Table 167. Key Raw Materials Lists
  • Table 168. Raw Materials Key Suppliers Lists
  • Table 169. Drug Rehabilitation Drugs Distributors List
  • Table 170. Drug Rehabilitation Drugs Customers List
  • Table 171. Drug Rehabilitation Drugs Market Trends
  • Table 172. Drug Rehabilitation Drugs Market Drivers
  • Table 173. Drug Rehabilitation Drugs Market Challenges
  • Table 174. Drug Rehabilitation Drugs Market Restraints
  • Table 175. Research Programs/Design for This Report
  • Table 176. Key Data Information from Secondary Sources
  • Table 177. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Drug Rehabilitation Drugs Product Picture
  • Figure 2. Global Drug Rehabilitation Drugs Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
  • Figure 3. Global Drug Rehabilitation Drugs Market Share by Type in 2022 & 2029
  • Figure 4. Opioids Product Picture
  • Figure 5. Non-opioid Drugs Product Picture
  • Figure 6. Global Drug Rehabilitation Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
  • Figure 7. Global Drug Rehabilitation Drugs Market Share by Application in 2022 & 2029
  • Figure 8. Hospital
  • Figure 9. Clinic
  • Figure 10. Drug Rehabilitation Drugs Report Years Considered
  • Figure 11. Global Drug Rehabilitation Drugs Revenue, (US$ Million), 2018 VS 2022 VS 2029
  • Figure 12. Global Drug Rehabilitation Drugs Revenue 2018-2029 (US$ Million)
  • Figure 13. Global Drug Rehabilitation Drugs Revenue Market Share by Region in Percentage: 2022 Versus 2029
  • Figure 14. Global Drug Rehabilitation Drugs Revenue Market Share by Region (2018-2029)
  • Figure 15. Global Drug Rehabilitation Drugs Sales 2018-2029 ((K Units)
  • Figure 16. Global Drug Rehabilitation Drugs Sales Market Share by Region (2018-2029)
  • Figure 17. US & Canada Drug Rehabilitation Drugs Sales YoY (2018-2029) & (K Units)
  • Figure 18. US & Canada Drug Rehabilitation Drugs Revenue YoY (2018-2029) & (US$ Million)
  • Figure 19. Europe Drug Rehabilitation Drugs Sales YoY (2018-2029) & (K Units)
  • Figure 20. Europe Drug Rehabilitation Drugs Revenue YoY (2018-2029) & (US$ Million)
  • Figure 21. China Drug Rehabilitation Drugs Sales YoY (2018-2029) & (K Units)
  • Figure 22. China Drug Rehabilitation Drugs Revenue YoY (2018-2029) & (US$ Million)
  • Figure 23. Asia (excluding China) Drug Rehabilitation Drugs Sales YoY (2018-2029) & (K Units)
  • Figure 24. Asia (excluding China) Drug Rehabilitation Drugs Revenue YoY (2018-2029) & (US$ Million)
  • Figure 25. Middle East, Africa and Latin America Drug Rehabilitation Drugs Sales YoY (2018-2029) & (K Units)
  • Figure 26. Middle East, Africa and Latin America Drug Rehabilitation Drugs Revenue YoY (2018-2029) & (US$ Million)
  • Figure 27. The Drug Rehabilitation Drugs Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
  • Figure 28. The Top 5 and 10 Largest Manufacturers of Drug Rehabilitation Drugs in the World: Market Share by Drug Rehabilitation Drugs Revenue in 2022
  • Figure 29. Global Drug Rehabilitation Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
  • Figure 30. Global Drug Rehabilitation Drugs Sales Market Share by Type (2018-2029)
  • Figure 31. Global Drug Rehabilitation Drugs Revenue Market Share by Type (2018-2029)
  • Figure 32. Global Drug Rehabilitation Drugs Sales Market Share by Application (2018-2029)
  • Figure 33. Global Drug Rehabilitation Drugs Revenue Market Share by Application (2018-2029)
  • Figure 34. US & Canada Drug Rehabilitation Drugs Sales Market Share by Type (2018-2029)
  • Figure 35. US & Canada Drug Rehabilitation Drugs Revenue Market Share by Type (2018-2029)
  • Figure 36. US & Canada Drug Rehabilitation Drugs Sales Market Share by Application (2018-2029)
  • Figure 37. US & Canada Drug Rehabilitation Drugs Revenue Market Share by Application (2018-2029)
  • Figure 38. US & Canada Drug Rehabilitation Drugs Revenue Share by Country (2018-2029)
  • Figure 39. US & Canada Drug Rehabilitation Drugs Sales Share by Country (2018-2029)
  • Figure 40. U.S. Drug Rehabilitation Drugs Revenue (2018-2029) & (US$ Million)
  • Figure 41. Canada Drug Rehabilitation Drugs Revenue (2018-2029) & (US$ Million)
  • Figure 42. Europe Drug Rehabilitation Drugs Sales Market Share by Type (2018-2029)
  • Figure 43. Europe Drug Rehabilitation Drugs Revenue Market Share by Type (2018-2029)
  • Figure 44. Europe Drug Rehabilitation Drugs Sales Market Share by Application (2018-2029)
  • Figure 45. Europe Drug Rehabilitation Drugs Revenue Market Share by Application (2018-2029)
  • Figure 46. Europe Drug Rehabilitation Drugs Revenue Share by Country (2018-2029)
  • Figure 47. Europe Drug Rehabilitation Drugs Sales Share by Country (2018-2029)
  • Figure 48. Germany Drug Rehabilitation Drugs Revenue (2018-2029) & (US$ Million)
  • Figure 49. France Drug Rehabilitation Drugs Revenue (2018-2029) & (US$ Million)
  • Figure 50. U.K. Drug Rehabilitation Drugs Revenue (2018-2029) & (US$ Million)
  • Figure 51. Italy Drug Rehabilitation Drugs Revenue (2018-2029) & (US$ Million)
  • Figure 52. Russia Drug Rehabilitation Drugs Revenue (2018-2029) & (US$ Million)
  • Figure 53. China Drug Rehabilitation Drugs Sales Market Share by Type (2018-2029)
  • Figure 54. China Drug Rehabilitation Drugs Revenue Market Share by Type (2018-2029)
  • Figure 55. China Drug Rehabilitation Drugs Sales Market Share by Application (2018-2029)
  • Figure 56. China Drug Rehabilitation Drugs Revenue Market Share by Application (2018-2029)
  • Figure 57. Asia Drug Rehabilitation Drugs Sales Market Share by Type (2018-2029)
  • Figure 58. Asia Drug Rehabilitation Drugs Revenue Market Share by Type (2018-2029)
  • Figure 59. Asia Drug Rehabilitation Drugs Sales Market Share by Application (2018-2029)
  • Figure 60. Asia Drug Rehabilitation Drugs Revenue Market Share by Application (2018-2029)
  • Figure 61. Asia Drug Rehabilitation Drugs Revenue Share by Region (2018-2029)
  • Figure 62. Asia Drug Rehabilitation Drugs Sales Share by Region (2018-2029)
  • Figure 63. Japan Drug Rehabilitation Drugs Revenue (2018-2029) & (US$ Million)
  • Figure 64. South Korea Drug Rehabilitation Drugs Revenue (2018-2029) & (US$ Million)
  • Figure 65. China Taiwan Drug Rehabilitation Drugs Revenue (2018-2029) & (US$ Million)
  • Figure 66. Southeast Asia Drug Rehabilitation Drugs Revenue (2018-2029) & (US$ Million)
  • Figure 67. India Drug Rehabilitation Drugs Revenue (2018-2029) & (US$ Million)
  • Figure 68. Middle East, Africa and Latin America Drug Rehabilitation Drugs Sales Market Share by Type (2018-2029)
  • Figure 69. Middle East, Africa and Latin America Drug Rehabilitation Drugs Revenue Market Share by Type (2018-2029)
  • Figure 70. Middle East, Africa and Latin America Drug Rehabilitation Drugs Sales Market Share by Application (2018-2029)
  • Figure 71. Middle East, Africa and Latin America Drug Rehabilitation Drugs Revenue Market Share by Application (2018-2029)
  • Figure 72. Middle East, Africa and Latin America Drug Rehabilitation Drugs Revenue Share by Country (2018-2029)
  • Figure 73. Middle East, Africa and Latin America Drug Rehabilitation Drugs Sales Share by Country (2018-2029)
  • Figure 74. Brazil Drug Rehabilitation Drugs Revenue (2018-2029) & (US$ Million)
  • Figure 75. Mexico Drug Rehabilitation Drugs Revenue (2018-2029) & (US$ Million)
  • Figure 76. Turkey Drug Rehabilitation Drugs Revenue (2018-2029) & (US$ Million)
  • Figure 77. Israel Drug Rehabilitation Drugs Revenue (2018-2029) & (US$ Million)
  • Figure 78. GCC Countries Drug Rehabilitation Drugs Revenue (2018-2029) & (US$ Million)
  • Figure 79. Drug Rehabilitation Drugs Value Chain
  • Figure 80. Drug Rehabilitation Drugs Production Process
  • Figure 81. Channels of Distribution
  • Figure 82. Distributors Profiles
  • Figure 83. Bottom-up and Top-down Approaches for This Report
  • Figure 84. Data Triangulation
  • Figure 85. Key Executives Interviewed
目次

This research report focuses on the Drug Rehabilitation Drugs Market. It analyzes market size, trends and demand forecasts, as well as growth factors and challenges. The report provides market data breakdowns by type, application, company, and region, in addition to competitive landscape and key company profiles.

TABLE OF CONTENTS

1 Study Coverage

  • 1.1 Drug Rehabilitation Drugs Product Introduction
  • 1.2 Market by Type
    • 1.2.1 Global Drug Rehabilitation Drugs Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
    • 1.2.2 Opioids
    • 1.2.3 Non-opioid Drugs
  • 1.3 Market by Application
    • 1.3.1 Global Drug Rehabilitation Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
    • 1.3.2 Hospital
    • 1.3.3 Clinic
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Executive Summary

  • 2.1 Global Drug Rehabilitation Drugs Sales Estimates and Forecasts 2018-2029
  • 2.2 Global Drug Rehabilitation Drugs Revenue by Region
    • 2.2.1 Global Drug Rehabilitation Drugs Revenue by Region: 2018 VS 2022 VS 2029
    • 2.2.2 Global Drug Rehabilitation Drugs Revenue by Region (2018-2023)
    • 2.2.3 Global Drug Rehabilitation Drugs Revenue by Region (2024-2029)
    • 2.2.4 Global Drug Rehabilitation Drugs Revenue Market Share by Region (2018-2029)
  • 2.3 Global Drug Rehabilitation Drugs Sales Estimates and Forecasts 2018-2029
  • 2.4 Global Drug Rehabilitation Drugs Sales by Region
    • 2.4.1 Global Drug Rehabilitation Drugs Sales by Region: 2018 VS 2022 VS 2029
    • 2.4.2 Global Drug Rehabilitation Drugs Sales by Region (2018-2023)
    • 2.4.3 Global Drug Rehabilitation Drugs Sales by Region (2024-2029)
    • 2.4.4 Global Drug Rehabilitation Drugs Sales Market Share by Region (2018-2029)
  • 2.5 US & Canada
  • 2.6 Europe
  • 2.7 China
  • 2.8 Asia (excluding China)
  • 2.9 Middle East, Africa and Latin America

3 Competition by Manufactures

  • 3.1 Global Drug Rehabilitation Drugs Sales by Manufacturers
    • 3.1.1 Global Drug Rehabilitation Drugs Sales by Manufacturers (2018-2023)
    • 3.1.2 Global Drug Rehabilitation Drugs Sales Market Share by Manufacturers (2018-2023)
    • 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Drug Rehabilitation Drugs in 2022
  • 3.2 Global Drug Rehabilitation Drugs Revenue by Manufacturers
    • 3.2.1 Global Drug Rehabilitation Drugs Revenue by Manufacturers (2018-2023)
    • 3.2.2 Global Drug Rehabilitation Drugs Revenue Market Share by Manufacturers (2018-2023)
    • 3.2.3 Global Top 10 and Top 5 Companies by Drug Rehabilitation Drugs Revenue in 2022
  • 3.3 Global Key Players of Drug Rehabilitation Drugs, Industry Ranking, 2021 VS 2022 VS 2023
  • 3.4 Global Drug Rehabilitation Drugs Sales Price by Manufacturers
  • 3.5 Analysis of Competitive Landscape
    • 3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
    • 3.5.2 Global Drug Rehabilitation Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.6 Global Key Manufacturers of Drug Rehabilitation Drugs, Manufacturing Base Distribution and Headquarters
  • 3.7 Global Key Manufacturers of Drug Rehabilitation Drugs, Product Offered and Application
  • 3.8 Global Key Manufacturers of Drug Rehabilitation Drugs, Date of Enter into This Industry
  • 3.9 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

  • 4.1 Global Drug Rehabilitation Drugs Sales by Type
    • 4.1.1 Global Drug Rehabilitation Drugs Historical Sales by Type (2018-2023)
    • 4.1.2 Global Drug Rehabilitation Drugs Forecasted Sales by Type (2024-2029)
    • 4.1.3 Global Drug Rehabilitation Drugs Sales Market Share by Type (2018-2029)
  • 4.2 Global Drug Rehabilitation Drugs Revenue by Type
    • 4.2.1 Global Drug Rehabilitation Drugs Historical Revenue by Type (2018-2023)
    • 4.2.2 Global Drug Rehabilitation Drugs Forecasted Revenue by Type (2024-2029)
    • 4.2.3 Global Drug Rehabilitation Drugs Revenue Market Share by Type (2018-2029)
  • 4.3 Global Drug Rehabilitation Drugs Price by Type
    • 4.3.1 Global Drug Rehabilitation Drugs Price by Type (2018-2023)
    • 4.3.2 Global Drug Rehabilitation Drugs Price Forecast by Type (2024-2029)

5 Market Size by Application

  • 5.1 Global Drug Rehabilitation Drugs Sales by Application
    • 5.1.1 Global Drug Rehabilitation Drugs Historical Sales by Application (2018-2023)
    • 5.1.2 Global Drug Rehabilitation Drugs Forecasted Sales by Application (2024-2029)
    • 5.1.3 Global Drug Rehabilitation Drugs Sales Market Share by Application (2018-2029)
  • 5.2 Global Drug Rehabilitation Drugs Revenue by Application
    • 5.2.1 Global Drug Rehabilitation Drugs Historical Revenue by Application (2018-2023)
    • 5.2.2 Global Drug Rehabilitation Drugs Forecasted Revenue by Application (2024-2029)
    • 5.2.3 Global Drug Rehabilitation Drugs Revenue Market Share by Application (2018-2029)
  • 5.3 Global Drug Rehabilitation Drugs Price by Application
    • 5.3.1 Global Drug Rehabilitation Drugs Price by Application (2018-2023)
    • 5.3.2 Global Drug Rehabilitation Drugs Price Forecast by Application (2024-2029)

6 US & Canada

  • 6.1 US & Canada Drug Rehabilitation Drugs Market Size by Type
    • 6.1.1 US & Canada Drug Rehabilitation Drugs Sales by Type (2018-2029)
    • 6.1.2 US & Canada Drug Rehabilitation Drugs Revenue by Type (2018-2029)
  • 6.2 US & Canada Drug Rehabilitation Drugs Market Size by Application
    • 6.2.1 US & Canada Drug Rehabilitation Drugs Sales by Application (2018-2029)
    • 6.2.2 US & Canada Drug Rehabilitation Drugs Revenue by Application (2018-2029)
  • 6.3 US & Canada Drug Rehabilitation Drugs Market Size by Country
    • 6.3.1 US & Canada Drug Rehabilitation Drugs Revenue by Country: 2018 VS 2022 VS 2029
    • 6.3.2 US & Canada Drug Rehabilitation Drugs Sales by Country (2018-2029)
    • 6.3.3 US & Canada Drug Rehabilitation Drugs Revenue by Country (2018-2029)
    • 6.3.4 US
    • 6.3.5 Canada

7 Europe

  • 7.1 Europe Drug Rehabilitation Drugs Market Size by Type
    • 7.1.1 Europe Drug Rehabilitation Drugs Sales by Type (2018-2029)
    • 7.1.2 Europe Drug Rehabilitation Drugs Revenue by Type (2018-2029)
  • 7.2 Europe Drug Rehabilitation Drugs Market Size by Application
    • 7.2.1 Europe Drug Rehabilitation Drugs Sales by Application (2018-2029)
    • 7.2.2 Europe Drug Rehabilitation Drugs Revenue by Application (2018-2029)
  • 7.3 Europe Drug Rehabilitation Drugs Market Size by Country
    • 7.3.1 Europe Drug Rehabilitation Drugs Revenue by Country: 2018 VS 2022 VS 2029
    • 7.3.2 Europe Drug Rehabilitation Drugs Sales by Country (2018-2029)
    • 7.3.3 Europe Drug Rehabilitation Drugs Revenue by Country (2018-2029)
    • 7.3.4 Germany
    • 7.3.5 France
    • 7.3.6 U.K.
    • 7.3.7 Italy
    • 7.3.8 Russia

8 China

  • 8.1 China Drug Rehabilitation Drugs Market Size
    • 8.1.1 China Drug Rehabilitation Drugs Sales (2018-2029)
    • 8.1.2 China Drug Rehabilitation Drugs Revenue (2018-2029)
  • 8.2 China Drug Rehabilitation Drugs Market Size by Application
    • 8.2.1 China Drug Rehabilitation Drugs Sales by Application (2018-2029)
    • 8.2.2 China Drug Rehabilitation Drugs Revenue by Application (2018-2029)

9 Asia (excluding China)

  • 9.1 Asia Drug Rehabilitation Drugs Market Size by Type
    • 9.1.1 Asia Drug Rehabilitation Drugs Sales by Type (2018-2029)
    • 9.1.2 Asia Drug Rehabilitation Drugs Revenue by Type (2018-2029)
  • 9.2 Asia Drug Rehabilitation Drugs Market Size by Application
    • 9.2.1 Asia Drug Rehabilitation Drugs Sales by Application (2018-2029)
    • 9.2.2 Asia Drug Rehabilitation Drugs Revenue by Application (2018-2029)
  • 9.3 Asia Drug Rehabilitation Drugs Sales by Region
    • 9.3.1 Asia Drug Rehabilitation Drugs Revenue by Region: 2018 VS 2022 VS 2029
    • 9.3.2 Asia Drug Rehabilitation Drugs Revenue by Region (2018-2029)
    • 9.3.3 Asia Drug Rehabilitation Drugs Sales by Region (2018-2029)
    • 9.3.4 Japan
    • 9.3.5 South Korea
    • 9.3.6 China Taiwan
    • 9.3.7 Southeast Asia
    • 9.3.8 India

10 Middle East, Africa and Latin America

  • 10.1 Middle East, Africa and Latin America Drug Rehabilitation Drugs Market Size by Type
    • 10.1.1 Middle East, Africa and Latin America Drug Rehabilitation Drugs Sales by Type (2018-2029)
    • 10.1.2 Middle East, Africa and Latin America Drug Rehabilitation Drugs Revenue by Type (2018-2029)
  • 10.2 Middle East, Africa and Latin America Drug Rehabilitation Drugs Market Size by Application
    • 10.2.1 Middle East, Africa and Latin America Drug Rehabilitation Drugs Sales by Application (2018-2029)
    • 10.2.2 Middle East, Africa and Latin America Drug Rehabilitation Drugs Revenue by Application (2018-2029)
  • 10.3 Middle East, Africa and Latin America Drug Rehabilitation Drugs Sales by Country
    • 10.3.1 Middle East, Africa and Latin America Drug Rehabilitation Drugs Revenue by Country: 2018 VS 2022 VS 2029
    • 10.3.2 Middle East, Africa and Latin America Drug Rehabilitation Drugs Revenue by Country (2018-2029)
    • 10.3.3 Middle East, Africa and Latin America Drug Rehabilitation Drugs Sales by Country (2018-2029)
    • 10.3.4 Brazil
    • 10.3.5 Mexico
    • 10.3.6 Turkey
    • 10.3.7 Israel
    • 10.3.8 GCC Countries

11 Company Profiles

  • 11.1 Teva
    • 11.1.1 Teva Company Information
    • 11.1.2 Teva Overview
    • 11.1.3 Teva Drug Rehabilitation Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.1.4 Teva Drug Rehabilitation Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.1.5 Teva Recent Developments
  • 11.2 Purdue Pharma
    • 11.2.1 Purdue Pharma Company Information
    • 11.2.2 Purdue Pharma Overview
    • 11.2.3 Purdue Pharma Drug Rehabilitation Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.2.4 Purdue Pharma Drug Rehabilitation Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.2.5 Purdue Pharma Recent Developments
  • 11.3 Mallinckrodt
    • 11.3.1 Mallinckrodt Company Information
    • 11.3.2 Mallinckrodt Overview
    • 11.3.3 Mallinckrodt Drug Rehabilitation Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.3.4 Mallinckrodt Drug Rehabilitation Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.3.5 Mallinckrodt Recent Developments
  • 11.4 Amneal Pharma
    • 11.4.1 Amneal Pharma Company Information
    • 11.4.2 Amneal Pharma Overview
    • 11.4.3 Amneal Pharma Drug Rehabilitation Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.4.4 Amneal Pharma Drug Rehabilitation Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.4.5 Amneal Pharma Recent Developments
  • 11.5 Collegium
    • 11.5.1 Collegium Company Information
    • 11.5.2 Collegium Overview
    • 11.5.3 Collegium Drug Rehabilitation Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.5.4 Collegium Drug Rehabilitation Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.5.5 Collegium Recent Developments
  • 11.6 J&J
    • 11.6.1 J&J Company Information
    • 11.6.2 J&J Overview
    • 11.6.3 J&J Drug Rehabilitation Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.6.4 J&J Drug Rehabilitation Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.6.5 J&J Recent Developments
  • 11.7 Endo
    • 11.7.1 Endo Company Information
    • 11.7.2 Endo Overview
    • 11.7.3 Endo Drug Rehabilitation Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.7.4 Endo Drug Rehabilitation Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.7.5 Endo Recent Developments
  • 11.8 Pfizer
    • 11.8.1 Pfizer Company Information
    • 11.8.2 Pfizer Overview
    • 11.8.3 Pfizer Drug Rehabilitation Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.8.4 Pfizer Drug Rehabilitation Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.8.5 Pfizer Recent Developments
  • 11.9 INSYS
    • 11.9.1 INSYS Company Information
    • 11.9.2 INSYS Overview
    • 11.9.3 INSYS Drug Rehabilitation Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.9.4 INSYS Drug Rehabilitation Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.9.5 INSYS Recent Developments
  • 11.10 Mylan
    • 11.10.1 Mylan Company Information
    • 11.10.2 Mylan Overview
    • 11.10.3 Mylan Drug Rehabilitation Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.10.4 Mylan Drug Rehabilitation Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.10.5 Mylan Recent Developments
  • 11.11 Hikma
    • 11.11.1 Hikma Company Information
    • 11.11.2 Hikma Overview
    • 11.11.3 Hikma Drug Rehabilitation Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.11.4 Hikma Drug Rehabilitation Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.11.5 Hikma Recent Developments
  • 11.12 Egalet
    • 11.12.1 Egalet Company Information
    • 11.12.2 Egalet Overview
    • 11.12.3 Egalet Drug Rehabilitation Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.12.4 Egalet Drug Rehabilitation Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.12.5 Egalet Recent Developments

12 Industry Chain and Sales Channels Analysis

  • 12.1 Drug Rehabilitation Drugs Industry Chain Analysis
  • 12.2 Drug Rehabilitation Drugs Key Raw Materials
    • 12.2.1 Key Raw Materials
    • 12.2.2 Raw Materials Key Suppliers
  • 12.3 Drug Rehabilitation Drugs Production Mode & Process
  • 12.4 Drug Rehabilitation Drugs Sales and Marketing
    • 12.4.1 Drug Rehabilitation Drugs Sales Channels
    • 12.4.2 Drug Rehabilitation Drugs Distributors
  • 12.5 Drug Rehabilitation Drugs Customers

13 Market Dynamics

  • 13.1 Drug Rehabilitation Drugs Industry Trends
  • 13.2 Drug Rehabilitation Drugs Market Drivers
  • 13.3 Drug Rehabilitation Drugs Market Challenges
  • 13.4 Drug Rehabilitation Drugs Market Restraints

14 Key Findings in The Global Drug Rehabilitation Drugs Study

15 Appendix

  • 15.1 Research Methodology
    • 15.1.1 Methodology/Research Approach
    • 15.1.2 Data Source
  • 15.2 Author Details
  • 15.3 Disclaimer